文献速递神经MR

基于MRI影像组学列线图的开发与外部验证:区分局限性星形细胞胶质瘤与弥漫性胶质瘤的多中心研究

Development and External Validation of an MRI-based Radiomics Nomogram to Distinguish Circumscribed Astrocytic Gliomas and Diffuse Gliomas: A Multicenter Study.
PubMed 文献 · Acad Radiol · 2023-07-26

该多中心回顾性研究纳入475例患者(弥漫性胶质瘤338例,局限性星形细胞胶质瘤137例),构建基于MRI不同感兴趣区的影像组学模型以区分两类胶质瘤。瘤周界面区模型表现最佳,外部验证集中联合模型AUC达0.94、PRAUC达0.959,提示瘤周区域影像组学具有鉴别潜力。

要点

  • 瘤周界面区影像组学模型区分局限性星形细胞胶质瘤与弥漫性胶质瘤优于瘤内模型。
  • 联合界面影像组学与临床特征的模型外部验证AUC为0.94、PRAUC为0.959。
  • 内部验证集瘤周界面区模型AUC为0.912、AUPRC为0.972。

核心结论

  • 纳入瘤周区域的影像组学模型在区分局限性星形细胞胶质瘤与弥漫性胶质瘤方面较瘤内模型更具潜力,可能有助于术前评估肿瘤性质并改善胶质瘤患者的临床管理。

研究设计与样本

  • 回顾性多中心研究,分析三家机构共475例患者的MRI数据(弥漫性胶质瘤338例,局限性星形细胞胶质瘤137例),构建瘤内及瘤周、全肿瘤、界面区三种VOI影像组学模型以及临床模型和联合模型,采用合成少数类过采样技术处理训练集不平衡。

诊断标准与关键数值

  • 瘤周界面区模型在交叉验证集中AUC为0.806、PRAUC为0.894;采用方差分析特征选择器和支持向量机分类器筛选出7个特征,该模型在内部验证集AUC为0.912、AUPRC为0.972,在外部验证集AUC为0.897、AUPRC为0.930;联合模型在外部验证集AUC为0.94、PRAUC为0.959。

临床应用与阅片要点

  • 作者认为瘤周区域影像组学模型在区分局限性星形细胞胶质瘤与弥漫性胶质瘤方面较瘤内模型更具潜力,可能有助于术前评估肿瘤性质并改善胶质瘤患者的临床管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The 5th edition of the World Health Organization classification of tumors of the Central Nervous System (WHO CNS) has introduced the term "diffuse" and its counterpart "circumscribed" to the category of gliomas. This study aimed to develop and validate models for distinguishing circumscribed astrocytic gliomas (CAGs) from diffuse gliomas (DGs).

MATERIALS AND METHODS: We retrospectively analyzed magnetic resonance imaging (MRI) data from patients with CAGs and DGs across three institutions. After tumor segmentation, three volume of interest (VOI) types were obtained: VOItumor and peritumor, VOIwhole, and VOIinterface. Clinical and combined models (incorporating radiomics and clinical features) were also established. To address imbalances in training dataset, Synthetic Minority Oversampling Technique was employed.

RESULTS: A total of 475 patients (DGs: n = 338, CAGs: n = 137) were analyzed. The VOIinterface model demonstrated the best performance for differentiating CAGs from DGs, achieving an area under the curve (AUC) of 0.806 and area under the precision-recall curve (PRAUC)of 0.894 in the cross-validation set. Using analysis of variance (ANOVA) feature selector and Support Vector Machine (SVM) classifier, seven features were selected. The model achieved an AUC and AUPRC of 0.912 and 0.972 in the internal validation dataset, and 0.897 and 0.930 in the external validation dataset. The combined model, incorporating interface radiomics and clinical features, showed improved performance in the external validation set, with an AUC of 0.94 and PRAUC of 0.959.

CONCLUSION: Radiomics models incorporating the peritumoral area demonstrate greater potential for distinguishing CAGs from DGs compared to intratumoral models. These findings may hold promise for evaluating tumor nature before surgery and improving clinical management of glioma patients.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Li S, Su X, Peng J, et al. Development and External Validation of an MRI-based Radiomics Nomogram to Distinguish Circumscribed Astrocytic Gliomas and Diffuse Gliomas: A Multicenter Study. Acad Radiol. 2023. PMID: 37507329. doi:10.1016/j.acra.2023.06.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。